These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12740258)

  • 41. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-1 Antitrypsin Levels and Polymorphisms in Interstitial Lung Diseases.
    Demir N; Erçen Diken Ö; Karabulut HG; Karnak D; Kayacan O
    Turk J Med Sci; 2017 Apr; 47(2):476-482. PubMed ID: 28425234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency.
    Stein PK; Nelson P; Rottman JN; Howard D; Ward SM; Kleiger RE; Senior RM
    Chest; 1998 Feb; 113(2):327-33. PubMed ID: 9498947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decline in FEV1 in patients with PiZ alpha-1-antitrypsin deficiency: the Australian experience.
    Burdon JG; Brenton S; Hocking V; Knight KR; Ayad M; Cook L; Janus ED
    Respirology; 2002 Mar; 7(1):51-5. PubMed ID: 11896901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study on the lung function in alpha 1-antitrypsin-deficient (PiMZ) patients.
    Kambe M; Morishita K; Tsubokura T; Tsuno K; Kimura T; Utsumi T; Kawamoto H; Yamakido M; Mittman C
    Hiroshima J Med Sci; 1993 Mar; 42(1):41-5. PubMed ID: 8486520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
    Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
    Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ.
    Seersholm N; Wilcke JT; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 2000 Jan; 161(1):81-4. PubMed ID: 10619801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.
    Malerba M; Ragnoli B; Radaeli A
    J Intern Med; 2009 Mar; 265(3):382-7. PubMed ID: 19019191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects.
    Malerba M; Ricciardolo F; Radaeli A; Torregiani C; Ceriani L; Mori E; Bontempelli M; Tantucci C; Grassi V
    Thorax; 2006 Feb; 61(2):129-33. PubMed ID: 16284217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?
    Seersholm N; Kok-Jensen A
    Respir Med; 1998 Feb; 92(2):241-5. PubMed ID: 9616519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterozygous alpha 1-antitrypsin deficiency (PiSZ) in an adolescent with asthma.
    Nuckton TJ; Beckerman RC
    South Med J; 1996 Oct; 89(10):1011-3. PubMed ID: 8865800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status.
    Tejwani V; Nowacki AS; Fye E; Sanders C; Stoller JK
    Respir Care; 2019 Aug; 64(8):915-922. PubMed ID: 30914495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials.
    Hutchison DC; Cooper D;
    Respir Med; 2002 Nov; 96(11):872-80. PubMed ID: 12418584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
    O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
    COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ.
    Wu MC; Eriksson S
    J Clin Epidemiol; 1988; 41(12):1157-65. PubMed ID: 3264848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis.
    Meyer P; Braun A; Roscher AA
    Clin Genet; 2002 Oct; 62(4):325-7. PubMed ID: 12372062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of the frequency of different phenotypes of alpha-1-antitrypsin in a population of Barcelona].
    Vidal R; Miravitlles M; Jardí R; Torrella M; Rodríguez-Frías F; Moral P; Vaqué J
    Med Clin (Barc); 1996 Jul; 107(6):211-4. PubMed ID: 8755448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency.
    Stolk J; Ng WH; Bakker ME; Reiber JH; Rabe KF; Putter H; Stoel BC
    Thorax; 2003 Dec; 58(12):1027-30. PubMed ID: 14645966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.
    McDonagh DJ; Nathan SP; Knudson RJ; Lebowitz MD
    J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.